Transcranial magnetic stimulation

A neuroscientific probe of cortical function in schizophrenia

Shawn M. McClintock, Catarina Freitas, Lindsay Oberman, Sarah H. Lisanby, Alvaro Pascual-Leone

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Transcranial magnetic stimulation (TMS) is a neuropsychiatric tool that can serve as a useful method to better understand the neurobiology of cognitive function, behavior, and emotional processing. The purpose of this article is to examine the utility of TMS as a means to measure neocortical function in neuropsychiatric disorders in general, and schizophrenia in particular, for the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia initiative. When incorporating TMS paradigms in research studies, methodologic considerations include technical aspects of TMS, cohort selection and confounding factors, and subject safety. Available evidence suggests benefits of TMS alone or in combination with neurophysiologic and neuroimaging methods, including positron emission tomography, single photon emission computed tomography, magnetic resonance imaging, functional magnetic resonance imaging, functional near infrared spectroscopy, magnetoencephalography, and electroencephalography, to explore neocortical function. With the multiple TMS techniques including single-pulse, paired-pulse, paired associative stimulation, and repetitive TMS and theta burst stimulation, combined with neurophysiologic and neuroimaging methods, there exists a plethora of TMS experimental paradigms to modulate neocortical physiologic processes. Specifically, TMS can measure cortical excitability, intracortical inhibitory and excitatory mechanisms, and local and network cortical plasticity. Coupled with functional and electrophysiologic modalities, TMS can provide insight into the mechanisms underlying healthy neurodevelopment and aging, as well as neuropsychiatric pathology. Thus, TMS could be a useful tool in the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia armamentarium of biomarker methods. Future investigations are warranted to optimize TMS methodologies for this purpose.

Original languageEnglish (US)
Pages (from-to)19-27
Number of pages9
JournalBiological Psychiatry
Volume70
Issue number1
DOIs
StatePublished - Jul 1 2011

Fingerprint

Transcranial Magnetic Stimulation
Schizophrenia
Cognition
Neuroimaging
Research
Magnetic Resonance Imaging
Magnetoencephalography
Near-Infrared Spectroscopy
Neurobiology
Single-Photon Emission-Computed Tomography
Positron-Emission Tomography
Electroencephalography
Biomarkers

Keywords

  • Biological marker
  • Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS)
  • cortical function
  • schizophrenia
  • TMS
  • transcranial magnetic stimulation

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Transcranial magnetic stimulation : A neuroscientific probe of cortical function in schizophrenia. / McClintock, Shawn M.; Freitas, Catarina; Oberman, Lindsay; Lisanby, Sarah H.; Pascual-Leone, Alvaro.

In: Biological Psychiatry, Vol. 70, No. 1, 01.07.2011, p. 19-27.

Research output: Contribution to journalArticle

McClintock, Shawn M. ; Freitas, Catarina ; Oberman, Lindsay ; Lisanby, Sarah H. ; Pascual-Leone, Alvaro. / Transcranial magnetic stimulation : A neuroscientific probe of cortical function in schizophrenia. In: Biological Psychiatry. 2011 ; Vol. 70, No. 1. pp. 19-27.
@article{cb2f97d526954823a2eb95b3d92d8d07,
title = "Transcranial magnetic stimulation: A neuroscientific probe of cortical function in schizophrenia",
abstract = "Transcranial magnetic stimulation (TMS) is a neuropsychiatric tool that can serve as a useful method to better understand the neurobiology of cognitive function, behavior, and emotional processing. The purpose of this article is to examine the utility of TMS as a means to measure neocortical function in neuropsychiatric disorders in general, and schizophrenia in particular, for the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia initiative. When incorporating TMS paradigms in research studies, methodologic considerations include technical aspects of TMS, cohort selection and confounding factors, and subject safety. Available evidence suggests benefits of TMS alone or in combination with neurophysiologic and neuroimaging methods, including positron emission tomography, single photon emission computed tomography, magnetic resonance imaging, functional magnetic resonance imaging, functional near infrared spectroscopy, magnetoencephalography, and electroencephalography, to explore neocortical function. With the multiple TMS techniques including single-pulse, paired-pulse, paired associative stimulation, and repetitive TMS and theta burst stimulation, combined with neurophysiologic and neuroimaging methods, there exists a plethora of TMS experimental paradigms to modulate neocortical physiologic processes. Specifically, TMS can measure cortical excitability, intracortical inhibitory and excitatory mechanisms, and local and network cortical plasticity. Coupled with functional and electrophysiologic modalities, TMS can provide insight into the mechanisms underlying healthy neurodevelopment and aging, as well as neuropsychiatric pathology. Thus, TMS could be a useful tool in the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia armamentarium of biomarker methods. Future investigations are warranted to optimize TMS methodologies for this purpose.",
keywords = "Biological marker, Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS), cortical function, schizophrenia, TMS, transcranial magnetic stimulation",
author = "McClintock, {Shawn M.} and Catarina Freitas and Lindsay Oberman and Lisanby, {Sarah H.} and Alvaro Pascual-Leone",
year = "2011",
month = "7",
day = "1",
doi = "10.1016/j.biopsych.2011.02.031",
language = "English (US)",
volume = "70",
pages = "19--27",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Transcranial magnetic stimulation

T2 - A neuroscientific probe of cortical function in schizophrenia

AU - McClintock, Shawn M.

AU - Freitas, Catarina

AU - Oberman, Lindsay

AU - Lisanby, Sarah H.

AU - Pascual-Leone, Alvaro

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Transcranial magnetic stimulation (TMS) is a neuropsychiatric tool that can serve as a useful method to better understand the neurobiology of cognitive function, behavior, and emotional processing. The purpose of this article is to examine the utility of TMS as a means to measure neocortical function in neuropsychiatric disorders in general, and schizophrenia in particular, for the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia initiative. When incorporating TMS paradigms in research studies, methodologic considerations include technical aspects of TMS, cohort selection and confounding factors, and subject safety. Available evidence suggests benefits of TMS alone or in combination with neurophysiologic and neuroimaging methods, including positron emission tomography, single photon emission computed tomography, magnetic resonance imaging, functional magnetic resonance imaging, functional near infrared spectroscopy, magnetoencephalography, and electroencephalography, to explore neocortical function. With the multiple TMS techniques including single-pulse, paired-pulse, paired associative stimulation, and repetitive TMS and theta burst stimulation, combined with neurophysiologic and neuroimaging methods, there exists a plethora of TMS experimental paradigms to modulate neocortical physiologic processes. Specifically, TMS can measure cortical excitability, intracortical inhibitory and excitatory mechanisms, and local and network cortical plasticity. Coupled with functional and electrophysiologic modalities, TMS can provide insight into the mechanisms underlying healthy neurodevelopment and aging, as well as neuropsychiatric pathology. Thus, TMS could be a useful tool in the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia armamentarium of biomarker methods. Future investigations are warranted to optimize TMS methodologies for this purpose.

AB - Transcranial magnetic stimulation (TMS) is a neuropsychiatric tool that can serve as a useful method to better understand the neurobiology of cognitive function, behavior, and emotional processing. The purpose of this article is to examine the utility of TMS as a means to measure neocortical function in neuropsychiatric disorders in general, and schizophrenia in particular, for the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia initiative. When incorporating TMS paradigms in research studies, methodologic considerations include technical aspects of TMS, cohort selection and confounding factors, and subject safety. Available evidence suggests benefits of TMS alone or in combination with neurophysiologic and neuroimaging methods, including positron emission tomography, single photon emission computed tomography, magnetic resonance imaging, functional magnetic resonance imaging, functional near infrared spectroscopy, magnetoencephalography, and electroencephalography, to explore neocortical function. With the multiple TMS techniques including single-pulse, paired-pulse, paired associative stimulation, and repetitive TMS and theta burst stimulation, combined with neurophysiologic and neuroimaging methods, there exists a plethora of TMS experimental paradigms to modulate neocortical physiologic processes. Specifically, TMS can measure cortical excitability, intracortical inhibitory and excitatory mechanisms, and local and network cortical plasticity. Coupled with functional and electrophysiologic modalities, TMS can provide insight into the mechanisms underlying healthy neurodevelopment and aging, as well as neuropsychiatric pathology. Thus, TMS could be a useful tool in the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia armamentarium of biomarker methods. Future investigations are warranted to optimize TMS methodologies for this purpose.

KW - Biological marker

KW - Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS)

KW - cortical function

KW - schizophrenia

KW - TMS

KW - transcranial magnetic stimulation

UR - http://www.scopus.com/inward/record.url?scp=79958857265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958857265&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2011.02.031

DO - 10.1016/j.biopsych.2011.02.031

M3 - Article

VL - 70

SP - 19

EP - 27

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 1

ER -